Sonova H Ag
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hea… Read more
Market Cap & Net Worth: Sonova H Ag (SOON)
Sonova H Ag (SW:SOON) has a market capitalization of $12.28 Billion (CHF11.24 Billion) as of March 18, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #1450 globally and #6 in its home market, demonstrating a -1.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sonova H Ag's stock price CHF188.60 by its total outstanding shares 59610666 (59.61 Million).
Sonova H Ag Market Cap History: 2015 to 2026
Sonova H Ag's market capitalization history from 2015 to 2026. Data shows growth from $7.31 Billion to $12.28 Billion (4.86% CAGR).
Index Memberships
Sonova H Ag is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
STOXX Europe Mid 200 EUR Price
MCXP
|
$181.70 Billion | 6.74% | #5 of 157 |
|
STOXX Europe Mid 200 EUR Net Return
MCXR
|
$181.70 Billion | 6.74% | #5 of 157 |
Weight: Sonova H Ag's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sonova H Ag Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sonova H Ag's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.49x
Sonova H Ag's market cap is 3.49 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
24.94x
Sonova H Ag's market cap is 24.94 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $7.21 Billion | $2.07 Billion | $337.03 Million | 3.48x | 21.40x |
| 2017 | $9.02 Billion | $2.40 Billion | $349.17 Million | 3.77x | 25.83x |
| 2018 | $9.66 Billion | $2.65 Billion | $400.13 Million | 3.65x | 24.14x |
| 2019 | $13.49 Billion | $2.76 Billion | $454.10 Million | 4.88x | 29.72x |
| 2020 | $14.11 Billion | $2.92 Billion | $483.20 Million | 4.84x | 29.19x |
| 2021 | $22.16 Billion | $2.60 Billion | $581.00 Million | 8.52x | 38.14x |
| 2022 | $13.79 Billion | $3.36 Billion | $649.00 Million | 4.10x | 21.25x |
| 2023 | $17.59 Billion | $3.74 Billion | $647.50 Million | 4.71x | 27.17x |
| 2024 | $19.29 Billion | $3.63 Billion | $601.00 Million | 5.32x | 32.10x |
| 2025 | $13.48 Billion | $3.87 Billion | $540.50 Million | 3.49x | 24.94x |
Competitor Companies of SOON by Market Capitalization
Companies near Sonova H Ag in the global market cap rankings as of March 18, 2026.
Key companies related to Sonova H Ag by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Sonova H Ag Historical Marketcap From 2015 to 2026
Between 2015 and today, Sonova H Ag's market cap moved from $7.31 Billion to $ 12.28 Billion, with a yearly change of 4.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF12.28 Billion | -8.93% |
| 2025 | CHF13.48 Billion | -30.10% |
| 2024 | CHF19.29 Billion | +9.63% |
| 2023 | CHF17.59 Billion | +27.56% |
| 2022 | CHF13.79 Billion | -37.76% |
| 2021 | CHF22.16 Billion | +57.10% |
| 2020 | CHF14.11 Billion | +4.53% |
| 2019 | CHF13.49 Billion | +39.68% |
| 2018 | CHF9.66 Billion | +7.10% |
| 2017 | CHF9.02 Billion | +25.08% |
| 2016 | CHF7.21 Billion | -1.36% |
| 2015 | CHF7.31 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Sonova H Ag was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.28 Billion USD |
| MoneyControl | $12.28 Billion USD |
| MarketWatch | $12.28 Billion USD |
| marketcap.company | $12.28 Billion USD |
| Reuters | $12.28 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.